Skip to content

Design of Study protocol for A Randomized Clinical Trial

Effect of aerobic Exercise on Ambulatory Blood Pressure Among Chinese Patients With Resistant Hypertension : Study protocol for A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061757
Enrollment
Unknown
Registered
2022-07-02
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Intervention group:Take antihypertensive drugs and Aerobic exercise
Routine treatment group :Take antihypertensive drugs

Sponsors

The Second Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnosis of resistant hypertension in accordance with the American Heart Association scientific statement,62. i.e. to have a mean systolic blood pressure of =130 mm Hg on 24-hour ambulatory blood pressure monitoring and/or >= 135 mm Hg during the day time hours, while taking maximally tolerated doses of at least three antihypertensive agents including a diuretic; or to have a controlled blood pressure with four or more antihypertensive agents62. 2. Men or women. 3. Age: 35 to 75 years old. 4. Unchanged medication in the previous 3 months. 5. Willing to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with secondary hypertension; 2. Evidence of target organ damage; 3. Patients with heart failure; 4. Previous cardiovascular event ; 5. Peripheral artery disease; 6. Renal failure; 7. Chronic obstructive pulmonary disease; 8. Systolic office blood pressure superior to 180 mmHg; 9. Biomechanical limitations to physical activity; 1O. Those participating in regular physical activity.

Design outcomes

Primary

MeasureTime frame
Changes of ambulatory blood pressure;

Secondary

MeasureTime frame
Office BP;Cardiopulmonary function;Quality of life;Arteriosclerosis;Autonomic nerve function;Body composition;Endothelial factor;Inflammatory factor;

Countries

China

Contacts

Public ContactXiaokang Wu
fwz2017@qq.com+86 29 87679344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026